Overview
What is Foundation For Innovative New Diagnostics?
Foundation For Innovative New Diagnostics (FIND) is a global nonprofit organization based in Geneva, Switzerland. With a mission to address diagnostic inequities and advance research and development (R&D) in low-resource areas, FIND plays a crucial role in enhancing access to essential diagnostic tools. In the context of the COVID-19 pandemic, FIND led major diagnostic manufacturing advancements, establishing capacity for 60 million COVID-19 rapid tests and self-tests per month in low- and middle-income countries (LMICs). This nonprofit organization has facilitated technology transfer programs, enabling local manufacturers like Diatropix (Senegal) and Premier Medical Corporation (India) to produce high-quality COVID-19 rapid diagnostic tests. FIND's efforts have resulted in WHO Emergency Use Listing (EUL) for several COVID-19 tests, helping bridge the diagnostic gap in resource-limited settings. Additionally, FIND supports decentralized community-based testing and test-and-treat strategies, ensuring effective implementation and monitoring of diagnostic solutions. With a workforce of 132 dedicated individuals, FIND acts as a catalyst in bridging the gap between technology development, policy, and clinical care, ultimately improving healthcare access in LMICs.
Official website here: www.finddx.org
What are the reviews and ratings of this charity?
Charity Navigator Rating: 85% (Three-Star out of Four Stars)
Foundation For Innovative New Diagnostics has received a positive rating of 85%, indicating a solid level of accountability and financial health within the organization. The charity boasts a fully independent board, which is crucial for governance, and has effective oversight mechanisms in place, as evidenced by its perfect scores for various accountability policies and practices. This reflects a commitment to transparency and ethical management.
The organization demonstrates a strong program expense ratio of 92.5%, which signifies that a significant portion of its expenditures is directed toward its programs rather than administrative costs. This efficiency suggests that funds are being utilized effectively to achieve the nonprofit's mission of improving diagnostic innovation for diseases, particularly in resource-limited settings.
However, while the overall score is commendable, there is always room for improvement in outreach and impact measurement. Potential donors should consider these factors along with the financial ratings to gauge the organization's overall effectiveness in delivering its mission and serving its target populations.
This AI summary has been generated from information found on Charity Navigator.
Is Foundation For Innovative New Diagnostics legitimate?
Foundation For Innovative New Diagnostics is a legitimate nonprofit organization registered as a 501(c)(3) entity. Foundation For Innovative New Diagnostics submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $2,368,660
Professional Fundraising Fees: $0
Other Salaries and Wages: $26,390,174
For more financial information, click here
Official website here: www.finddx.org
What is the mission statement of Foundation For Innovative New Diagnostics?
Foundation For Innovative New Diagnostics (FIND) is an international non-profit organization dedicated to enabling the development and delivery of essential diagnostic tests for poverty-related diseases. FIND acts as a catalyst, bridging the gap between experts in technology development, policy, and clinical care. By reducing barriers to innovation and effective implementation, FIND facilitates the accessibility of diagnostic solutions in low- and middle-income countries.
Official website here: www.finddx.org
Who is the CEO of Foundation For Innovative New Diagnostics?
Daniel Bausch is the CEO of Foundation For Innovative New Diagnostics The CEO's salary of Foundation For Innovative New Diagnostics is $212,735 and their total compensation is $268,590.
Official website here: www.finddx.org
What is the revenue of Foundation For Innovative New Diagnostics?
Foundation For Innovative New Diagnostics's revenue in 2023 was $90,612,477.
Official website here: www.finddx.org
Who are the executives of Foundation For Innovative New Diagnostics and what are their salaries?
The average compensation at Foundation For Innovative New Diagnostics during 2023 was $195,638. There are 147 employees and 8 volunteers at Foundation For Innovative New Diagnostics.
Here are 28 key members and their salaries (Foundation For Innovative New Diagnostics's CEO's salary is $212,735 and their total compensation is $268,590):
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $266,651
- Related: $0
- Other: $66,966
- Compensation: $247,968
- Related: $0
- Other: $53,498
- Compensation: $267,747
- Related: $0
- Other: $62,926
- Compensation: $329,322
- Related: $0
- Other: $84,426
- Compensation: $145,082
- Related: $0
- Other: $16,250
- Compensation: $342,556
- Related: $0
- Other: $74,970
- Compensation: $252,163
- Related: $0
- Other: $63,150
- Compensation: $397,275
- Related: $0
- Other: $100,961
- Compensation: $320,525
- Related: $0
- Other: $0
- Compensation: $212,735
- Related: $0
- Other: $55,855
- Compensation: $238,003
- Related: $0
- Other: $0
- Compensation: $246,488
- Related: $0
- Other: $54,956
- Compensation: $254,026
- Related: $0
- Other: $30,113
- Compensation: $254,024
- Related: $0
- Other: $55,870
- Compensation: $230,390
- Related: $0
- Other: $54,167
- Compensation: $235,512
- Related: $0
- Other: $43,469
Official website here: www.finddx.org
Where can I find the form 990 for Foundation For Innovative New Diagnostics?
Foundation For Innovative New Diagnostics's most recent form 990 was submitted in 2023 and can be accessed here.
Official website here: www.finddx.org
Learn more at the official website: www.finddx.org
Mission Statement of Foundation For Innovative New Diagnostics
Foundation For Innovative New Diagnostics (FIND) is a international non-profit organization that facilitates the creation and distribution of affordable diagnostic tests for poverty-related diseases in low- and middle-income countries. Acting as a bridge between technology developers, policymakers, and clinical care providers, FIND reduces barriers to innovation and ensures the effective implementation of diagnostic solutions in resource-limited settings. By enabling the development and delivery of necessary diagnostic tests, FIND aims to improve health outcomes and save lives.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Foundation for Innovative New Diagnostics (FIND) has significantly impacted global healthcare by advancing the development and implementation of affordable diagnostics for infectious diseases, particularly in low-resource areas.
In response to the COVID-19 pandemic, FIND invested over $103 million in 2022 to tackle access inequities and enhance diagnostics research and development. Their efforts led to the establishment of manufacturing capacities in low- and middle-income countries (LMICs), producing 60 million COVID-19 rapid tests (RDTs) and self-tests monthly, with prices ranging from $1 to $2 per test.
FIND facilitated technology transfer programs enabling various companies, such as Diatropix in Senegal and Premier Medical Corporation in India, to manufacture high-quality RDTs and expand production capabilities. Their collaborations achieved important milestones, such as enabling WHO Emergency Use Listing for multiple COVID-19 tests and supporting independent trial data that informed international health policies.
Moreover, FIND has assessed the performance of over 50 COVID-19 diagnostic tests, including the accuracy of Ag RDTs, adapting to new variants, and expanding testing strategies into unconventional settings. Their comprehensive monitoring of testing and sequencing capacity has shaped effective responses to the pandemic.
By procuring nearly 1.9 million diagnostic tests for 26 countries and facilitating decentralized community-based testing processes, FIND has played a crucial role in ensuring that essential diagnostics are accessible, thus improving health outcomes in vulnerable populations affected by infectious diseases.
This information is meant to be a general summary of Foundation For Innovative New Diagnostics. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2023.
- Investment Income: $3,411,063
- Gross Receipts: $90,612,477
Assets and Liabilities:
- Total Assets: $137,542,319
- Total Liabilities: $115,874,802
- Net Assets: $21,667,517
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2003
Principal Officer
Norma Torres
Website
www.finddx.orgNTEE Category
Code: H80 - Medical research
If you are a representative of Foundation For Innovative New Diagnostics and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.